Zum Inhalt springen Zur Suche springen

News-Detail

Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease.
Thomas Grüter et al., JAMA Neurol. [in press]

Thomas Grüter, Carles Gaig, Yvette S Crijnen, Maarten J Titulaer, Lidia Sabater, Anna Heidbreder, Justina Dargvainiene, Anja Tietz, Stjepana Kovac, Andre Dik, María Elena Erro, Jan Lewerenz, Andrea Kraft, Frank Seifert, Romana Höftberger, Franziska S Thaler, Lucie de Azevedo, Jonathan Wickel, Juna M de Vries, Agnita J W Boon, Robin W van Steenhoven, Ralf Gold, Klaus-Peter Wandinger, Gregor Kuhlenbäumer, Josep O Dalmau, Frank Leypoldt, Francesc Graus, Ilya Ayzenberg; Anti-IgLON5 Disease Study Group.

Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease.

JAMA Neurol. 2025 Aug 4:e252574. doi: 10.1001/jamaneurol.2025.2574. [Epub ahead of print] PubMed ID: 40758377

 

Further Information:

DOI: 10.1001/jamaneurol.2025.2574

Nico Melzer

Sven Meuth

Kategorie/n: NND-Publikationen